Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma. [PDF]
Zhang Z +9 more
europepmc +1 more source
Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma [PDF]
Carmen Oi Ning Leung +10 more
openalex +1 more source
Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. [PDF]
Chen X +5 more
europepmc +1 more source
Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma. [PDF]
Huang C, Li Y, Zhang F, Zhang C, Ding Z.
europepmc +1 more source
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. [PDF]
Guo M +9 more
europepmc +1 more source
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
Kai Liu +5 more
openalex +2 more sources
Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation. [PDF]
He G +5 more
europepmc +1 more source
SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma
Jugang Wu +4 more
openalex +1 more source

